ADOPTION AS A MISSING LINK IN HEOR: EVIDENCE MAPPING OF HEALTHCARE INNOVATION UPTAKE
Author(s)
Borbála Biró, MSc.
University of Pecs, Faculty of Business and Economics, Pécs, Hungary.
University of Pecs, Faculty of Business and Economics, Pécs, Hungary.
OBJECTIVES: Adoption and sustained use determine whether healthcare innovations deliver real-world value. This review maps managerial and organizational determinants of healthcare innovation adoption and examines how frequently these determinants are linked to endpoints relevant to health economics and outcomes research (HEOR) and health technology assessment (HTA).
METHODS: I conducted a systematic literature search following the PRISMA guidelines, searching Scopus and Web of Science for English-language, peer-reviewed Business/Management articles published between 2001 and 2023 (search date: January 2, 2024). Records were required to include the terms “healthcare,” “innovation,” and “adoption” in the title, abstract, or keywords. After deduplication and screening, eligible studies were synthesized thematically. Keyword co-occurrence mapping and clustering were conducted using VOSviewer to characterize research domains.
RESULTS: From 235 initial records, 130 studies were selected for thematic synthesis. Thematic synthesis revealed four primary research streams. While studies on patient and clinician acceptance (1) focused heavily on TAM/UTAUT frameworks, highlighting trust and institutional support, research into IT-enabled innovations (3) shifted the emphasis toward privacy risks and data interoperability. Between these clusters, a common gap emerged: although organizational determinants (4), like leadership and governance, are well-documented, their quantitative impact on long-term uptake remains under-researched. Across clusters, determinants were frequently described, but few studies quantified their effects on uptake or persistence or linked them to downstream utilization, outcomes, or costs.
CONCLUSIONS: Adoption determinants are well described but are not consistently integrated into the formal economic evaluations or reimbursement frameworks that inform policy and market access. HEOR studies would benefit from explicitly measuring and modeling uptake and persistence, capturing implementation context and organizational readiness, and using scenario and sensitivity analyses to reflect adoption uncertainty in reimbursement and scale-up decisions.
METHODS: I conducted a systematic literature search following the PRISMA guidelines, searching Scopus and Web of Science for English-language, peer-reviewed Business/Management articles published between 2001 and 2023 (search date: January 2, 2024). Records were required to include the terms “healthcare,” “innovation,” and “adoption” in the title, abstract, or keywords. After deduplication and screening, eligible studies were synthesized thematically. Keyword co-occurrence mapping and clustering were conducted using VOSviewer to characterize research domains.
RESULTS: From 235 initial records, 130 studies were selected for thematic synthesis. Thematic synthesis revealed four primary research streams. While studies on patient and clinician acceptance (1) focused heavily on TAM/UTAUT frameworks, highlighting trust and institutional support, research into IT-enabled innovations (3) shifted the emphasis toward privacy risks and data interoperability. Between these clusters, a common gap emerged: although organizational determinants (4), like leadership and governance, are well-documented, their quantitative impact on long-term uptake remains under-researched. Across clusters, determinants were frequently described, but few studies quantified their effects on uptake or persistence or linked them to downstream utilization, outcomes, or costs.
CONCLUSIONS: Adoption determinants are well described but are not consistently integrated into the formal economic evaluations or reimbursement frameworks that inform policy and market access. HEOR studies would benefit from explicitly measuring and modeling uptake and persistence, capturing implementation context and organizational readiness, and using scenario and sensitivity analyses to reflect adoption uncertainty in reimbursement and scale-up decisions.
Conference/Value in Health Info
2026-05, ISPOR 2026, Philadelphia, PA, USA
Value in Health, Volume 29, Issue S6
Code
OP2
Topic
Organizational Practices
Disease
No Additional Disease & Conditions/Specialized Treatment Areas